Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 57642Generated: October 26, 2026

1-(4-(Trimethylstannyl)phenyl)piperidin-4-ol → (R)-tert-butyl 2-((7-(4-(4-hydroxypiperidin-1-yl)phenyl)pyrido[4,3-b]pyrazin-5-ylamino)methyl)morpholine-4-carboxylate

https://huagongshe.com/reaction/57642

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-(4-(Trimethylstannyl)phenyl)piperidin-4-olHCID 71093682—
Reactant(R)-tert-butyl 2-((7-chloropyrido[4,3-b]pyrazin-5-ylamino)methyl)morpholine-4-carboxylateHCID 86706988—
CatalystHCID 178418397HCID 178418397—
SolventTolueneHCID 1140—
Product(R)-tert-butyl 2-((7-(4-(4-hydroxypiperidin-1-yl)phenyl)pyrido[4,3-b]pyrazin-5-ylamino)methyl)morpholine-4-carboxylateHCID 8671740027.6%

Reaction Steps

1-(4-(trimethylstannyl)phenyl)piperidin-4-ol (398 mg, 1.17 mmol), (R)-tert-butyl 2-((7-chloropyrido[4,3-b]pyrazin-5-ylamino)methyl)morpholine-4-carboxylate (297 mg, 0.78 mmol), tetrakis(triphenylphosphine)palladium (180 mg, 0.15 mmol) were mixed in 5 mL toluene. The mixture was reacted at 100° C. overnight. Filtrated and concentrated, purified by flash chromatography (PE:EA=1:2) to give 112 mg reddish solid.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09434726B2
Source datasetuspto-grants-2016_09
ORD IDord-c0cad0a5575a4ad8be1364d8ccd5a2c8
Source noteuspto-grants-2016_09